NO20065480L - Vaksiner. - Google Patents

Vaksiner.

Info

Publication number: NO20065480L
Authority: NO; Norway
Prior art keywords: antigen; vaccines; eso; saponin; adjuvant
Prior art date: 2004-05-04

Application number

NO20065480A

Other languages

English (en)

Norwegian (no)

Inventor

Remi M Palmantier

Claudine Elvire Marie Bruck

Vincent Brichard

Melinda Meaders

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-04

Filing date

2006-11-28

Publication date

2006-11-28

2006-11-28 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2006-11-28 Publication of NO20065480L publication Critical patent/NO20065480L/no

Links

229960005486 vaccine Drugs 0.000 title abstract 3
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
102100025570 Cancer/testis antigen 1 Human genes 0.000 abstract 1
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 abstract 1
101001005719 Homo sapiens Melanoma-associated antigen 3 Proteins 0.000 abstract 1
102100025082 Melanoma-associated antigen 3 Human genes 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
108091034117 Oligonucleotide Proteins 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
230000003308 immunostimulating effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
229930182490 saponin Natural products 0.000 abstract 1
150000007949 saponins Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001188—NY-ESO
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

NO20065480A 2004-05-04 2006-11-28 Vaksiner. NO20065480L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0409940.4A GB0409940D0 (en)	2004-05-04	2004-05-04	Vaccine
PCT/EP2005/004956 WO2005105139A2 (en)	2004-05-04	2005-05-02	Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy

Publications (1)

Publication Number	Publication Date
NO20065480L true NO20065480L (no)	2006-11-28

Family

ID=32482653

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065480A NO20065480L (no)	2004-05-04	2006-11-28	Vaksiner.

Country Status (16)

Country	Link
US (1)	US20070243196A1 (pt)
EP (1)	EP1755657A2 (pt)
JP (1)	JP2007536326A (pt)
CN (1)	CN1980691A (pt)
AU (1)	AU2005237256A1 (pt)
BR (1)	BRPI0510570A (pt)
CA (1)	CA2564470A1 (pt)
GB (1)	GB0409940D0 (pt)
IL (1)	IL178681A0 (pt)
MA (1)	MA28639B1 (pt)
MX (1)	MXPA06012723A (pt)
NO (1)	NO20065480L (pt)
NZ (1)	NZ550967A (pt)
RU (1)	RU2006138283A (pt)
WO (1)	WO2005105139A2 (pt)
ZA (1)	ZA200608693B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007137986A2 (en) *	2006-05-26	2007-12-06	Glaxosmithkline Biologicals Sa	Vaccination against cancer
GB0612342D0 (en) *	2006-06-21	2006-08-02	Glaxosmithkline Biolog Sa	Method
EP2118128B1 (en) *	2007-01-15	2012-11-07	GlaxoSmithKline Biologicals SA	Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
EP2125888B1 (en)	2007-03-13	2015-12-02	University of Zurich	Method of providing human tumor-specific antibodies
AR066676A1 (es)	2007-05-24	2009-09-02	Glaxosmithkline Biolog Sa	Composicion antigenica liofilizada que contiene un agonista del receptor tipo toll
WO2009127666A2 (en) *	2008-04-15	2009-10-22	Glaxosmithkline Biologicals S.A.	Method and compositions
CN101381402B (zh) *	2008-10-20	2011-06-01	中国人民解放军第三军医大学	Ny-eso-1肿瘤抗原模拟表位及其应用
US20120039993A1 (en)	2009-03-17	2012-02-16	Glaxosmithkline Biologicals Sa	Detection of Gene Expression
GB0910046D0 (en)	2009-06-10	2009-07-22	Glaxosmithkline Biolog Sa	Novel compositions
ES2617983T3 (es) *	2011-01-10	2017-06-20	Ct Atlantic Ltd.	Terapia de combinación que incluye anticuerpos de unión a antígenos asociados a tumores
GB201116248D0 (en)	2011-09-20	2011-11-02	Glaxosmithkline Biolog Sa	Liposome production using isopropanol
PL3542819T3 (pl) *	2013-05-14	2022-01-10	Zoetis Services Llc	Nowe kompozycje szczepionek zawierających oligonukleotydy immunostymulujące
JP6697384B2 (ja)	2013-07-25	2020-05-20	イグジキュア, インコーポレーテッドExicure, Inc.	予防的および治療的使用のための免疫刺激剤としての球状の核酸ベース構築物
ES2725948T3 (es)	2014-06-04	2019-09-30	Exicure Inc	Suministro multivalente de inmunomoduladores mediante ácidos nucleicos esféricos liposomales para aplicaciones profilácticas o terapéuticas
GB201413665D0 (en)	2014-07-03	2014-09-17	Transimmune Ag And Yale University	Method for obtaining globally activated monocytes
WO2016019298A2 (en) *	2014-08-01	2016-02-04	Texas Tech University System	Cancer testis antigen sperm protein 17 as a target for breast cancer immunotherapy and diagnosis
US11213593B2 (en)	2014-11-21	2022-01-04	Northwestern University	Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
WO2018039629A2 (en)	2016-08-25	2018-03-01	Northwestern University	Micellar spherical nucleic acids from thermoresponsive, traceless templates
US11696954B2 (en)	2017-04-28	2023-07-11	Exicure Operating Company	Synthesis of spherical nucleic acids using lipophilic moieties
WO2018226931A1 (en) *	2017-06-07	2018-12-13	David Weiner	Mage-a vaccines and methods of treatment using the same
WO2019061297A1 (zh) *	2017-09-29	2019-04-04	苏州工业园区唯可达生物科技有限公司	一种cd4辅助性t细胞表位融合肽及其疫苗
GB201804468D0 (en) *	2018-03-21	2018-05-02	Valo Therapeutics Oy	PeptiCRAd Cancer Therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5057540A (en) *	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US5278302A (en) *	1988-05-26	1994-01-11	University Patents, Inc.	Polynucleotide phosphorodithioates
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
FR2649013B1 (fr) *	1989-07-03	1991-10-25	Seppic Sa	Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
FR2649012B1 (fr) *	1989-07-03	1991-10-25	Seppic Sa	Emulsions multiphasiques injectables
EP0882246A1 (en) *	1996-02-23	1998-12-09	BRITISH TELECOMMUNICATIONS public limited company	Optical interconnect
DE69943359D1 (de) *	1998-02-05	2011-05-26	Glaxosmithkline Biolog Sa	Tumorassoziierte Antigenderivate der Mage-Familie, zur Herstellung von Fusionsproteinen mit T-Helper Epitope und Zusammensetzungen zur Impfung
US6686147B1 (en) *	1998-07-15	2004-02-03	Ludwig Institute For Cancer Research	Cancer associated antigens and uses therefor
US20030044813A1 (en) *	2001-03-30	2003-03-06	Old Lloyd J.	Cancer-testis antigens

2004
- 2004-05-04 GB GBGB0409940.4A patent/GB0409940D0/en not_active Ceased
2005
- 2005-05-02 JP JP2007512044A patent/JP2007536326A/ja active Pending
- 2005-05-02 CA CA002564470A patent/CA2564470A1/en not_active Abandoned
- 2005-05-02 MX MXPA06012723A patent/MXPA06012723A/es not_active Application Discontinuation
- 2005-05-02 RU RU2006138283/15A patent/RU2006138283A/ru not_active Application Discontinuation
- 2005-05-02 NZ NZ550967A patent/NZ550967A/en unknown
- 2005-05-02 BR BRPI0510570-6A patent/BRPI0510570A/pt not_active IP Right Cessation
- 2005-05-02 WO PCT/EP2005/004956 patent/WO2005105139A2/en active Application Filing
- 2005-05-02 AU AU2005237256A patent/AU2005237256A1/en not_active Abandoned
- 2005-05-02 US US11/568,566 patent/US20070243196A1/en not_active Abandoned
- 2005-05-02 EP EP05741937A patent/EP1755657A2/en not_active Withdrawn
- 2005-05-02 CN CNA2005800137978A patent/CN1980691A/zh active Pending
2006
- 2006-10-17 IL IL178681A patent/IL178681A0/en unknown
- 2006-10-18 ZA ZA200608693A patent/ZA200608693B/xx unknown
- 2006-11-28 NO NO20065480A patent/NO20065480L/no not_active Application Discontinuation
- 2006-11-28 MA MA29494A patent/MA28639B1/fr unknown

Also Published As

Publication number	Publication date
IL178681A0 (en)	2007-02-11
JP2007536326A (ja)	2007-12-13
GB0409940D0 (en)	2004-06-09
NZ550967A (en)	2009-01-31
CA2564470A1 (en)	2005-11-10
BRPI0510570A (pt)	2007-11-20
MXPA06012723A (es)	2007-02-14
EP1755657A2 (en)	2007-02-28
US20070243196A1 (en)	2007-10-18
AU2005237256A1 (en)	2005-11-10
MA28639B1 (fr)	2007-06-01
ZA200608693B (en)	2010-01-27
WO2005105139A3 (en)	2006-04-13
WO2005105139A2 (en)	2005-11-10
RU2006138283A (ru)	2008-06-10
CN1980691A (zh)	2007-06-13

Legal Events

Date	Code	Title	Description
2010-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20065480L (no)	2006-11-28	Vaksiner.
WO2006042254A3 (en)	2006-11-09	Adjuvant for dna vaccines
CY1118372T1 (el)	2017-06-28	Νεα μεθοδος και συνθεσεις
NO20015073D0 (no)	2001-10-18	Vaksiner
CR11122A (es)	2010-03-22	Vacuna de influenza de emulsion de aceite en agua
ATE426412T1 (de)	2009-04-15	Adjuvante influenza-vakzine
NO20090897L (no)	2009-05-29	Vaksine
HUP0402067A2 (hu)	2005-01-28	Oltóanyagok
GB2434367A (en)	2007-07-25	Improved vaccines
ATE474931T1 (de)	2010-08-15	Epitop-synchronisierung in antigen präsentierenden zellen
ATE491467T1 (de)	2011-01-15	Impfstoffzusammensetzungen mit virosomen und einem saponin-adjuvans
CY1116904T1 (el)	2017-04-05	Εμβολιο
DK1104306T3 (da)	2006-05-22	Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
TW200722101A (en)	2007-06-16	Novel composition
ATE542829T1 (de)	2012-02-15	Impfstoff
GB0123580D0 (en)	2001-11-21	Vaccine
WO2007052165A3 (en)	2007-10-25	A lentiviral vector-based vaccine
CA2763359C (en)	2021-07-27	New human rotavirus strains and vaccines
UY31285A1 (es)	2009-03-31	Vacunas
WO2016207853A3 (en)	2017-02-23	Antigenically matched influenza vaccines
GB2386072A (en)	2003-09-10	Novel vaccine
CY1112658T1 (el)	2016-02-10	Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d
ATE392216T1 (de)	2008-05-15	Mycobakterieller impfstoff
GB2444676A (en)	2008-06-11	Adjuvanted vaccine
DE60336927D1 (pt)	2011-06-09